Your browser doesn't support javascript.
Case Report: A Re-Positive Case of SARS-CoV-2 Associated With Glaucoma.
Zhou, Xiaoli; Zhou, Ya-Na; Ali, Ashaq; Liang, Cuiqin; Ye, Zhiqin; Chen, Xiaomin; Zhang, Qing; Deng, Lihua; Sun, Xinyi; Zhang, Qian; Luo, Jihong; Li, Wei; Zhou, Kun; Cao, Shanshan; Zhang, Xiaowei; Li, Xiao-Dong; Zhang, Xian-En; Cui, Zongqiang; Men, Dong.
  • Zhou X; Hubei Province Hospital of Traditional Chinese Medicine, Wuhan, China.
  • Zhou YN; Hubei Province Hospital of Traditional Chinese Medicine, Wuhan, China.
  • Ali A; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Liang C; University of Chinese Academy of Sciences, Beijing, China.
  • Ye Z; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Chen X; Hubei Province Hospital of Traditional Chinese Medicine, Wuhan, China.
  • Zhang Q; Hubei Province Hospital of Traditional Chinese Medicine, Wuhan, China.
  • Deng L; Hubei Province Hospital of Traditional Chinese Medicine, Wuhan, China.
  • Sun X; Hubei Province Hospital of Traditional Chinese Medicine, Wuhan, China.
  • Zhang Q; Hubei Province Hospital of Traditional Chinese Medicine, Wuhan, China.
  • Luo J; Hubei Province Hospital of Traditional Chinese Medicine, Wuhan, China.
  • Li W; Hubei Province Hospital of Traditional Chinese Medicine, Wuhan, China.
  • Zhou K; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Cao S; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Zhang X; University of Chinese Academy of Sciences, Beijing, China.
  • Li XD; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Zhang XE; State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.
  • Cui Z; Hubei Province Hospital of Traditional Chinese Medicine, Wuhan, China.
  • Men D; First Clinical College, Hubei University of Chinese Medicine, Wuhan, China.
Front Immunol ; 12: 701295, 2021.
Article in English | MEDLINE | ID: covidwho-1359190
ABSTRACT
The current pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has already become a global threat to the human population. Infection with SARS-CoV-2 leads to a wide spectrum of clinical manifestations. Ocular abnormalities have been reported in association with COVID-19, but the nature of the impairments was not specified. Here, we report a case of a female patient diagnosed with glaucoma on re-hospitalization for ocular complications two months after being discharged from the hospital upon recovery from COVID-19. Meanwhile, the patient was found re-positive for SARS-CoV-2 in the upper respiratory tract. The infection was also diagnosed in the aqueous humor through immunostaining with antibodies against the N protein and S protein of SARS-CoV-2. Considering the eye is an immune-privileged site, we speculate that SARS-CoV-2 survived in the eye and resulted in the patient testing re-positive for SARS-CoV-2.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Aqueous Humor / Glaucoma / Reinfection / COVID-19 Type of study: Case report / Prognostic study Topics: Long Covid Limits: Aged / Female / Humans Language: English Journal: Front Immunol Year: 2021 Document Type: Article Affiliation country: Fimmu.2021.701295

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Aqueous Humor / Glaucoma / Reinfection / COVID-19 Type of study: Case report / Prognostic study Topics: Long Covid Limits: Aged / Female / Humans Language: English Journal: Front Immunol Year: 2021 Document Type: Article Affiliation country: Fimmu.2021.701295